TY  - JOUR
AU  - García-Garrido, Eduardo 
AU  - Cordani, Marco
AU  - Somoza, Álvaro 
PY  - 2021
DO  - 10.3390/pharmaceutics13122067
SN  - 1999-4923
UR  - https://hdl.handle.net/20.500.14352/97194
T2  - Pharmaceutics
AB  - Mutant p53 proteins result from missense mutations in the TP53 gene, the most mutated in human cancer, and have been described to contribute to cancer initiation and progression. Therapeutic strategies for targeting mutant p53 proteins in cancer cells...
LA  - eng
M2  - 2067
PB  - MDPI
KW  - Cancer therapy 
KW  - Drug delivery
KW  - Gold nanoparticles
KW  - Mutant p53
KW  - Nanomedicine
KW  - Nucleic acids
TI  - Modified Gold Nanoparticles to Overcome the Chemoresistance to Gemcitabine in Mutant p53 Cancer Cells
TY  - journal article
VL  - 13
ER  -